PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA. Electronic address: Tab2006@med.cornell.edu.\', \'Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA.\', \'Comprehensive Center for Brain Health, Departments of Neurology and Psychiatry, University of Miami, Miller School of Medicine, Boca Raton, FL 33433, USA.\', \'Brain Health Imaging Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA.\', \'Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA.\', \'OTB Research, Charleston, SC, USA.\', \'Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, and Geriatric Research, Education and Clinical Center, Veterans Administration Hospital, Madison, WI 53705, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1551-7144(21)00224-X10.1016/j.cct.2021.106488
?:hasPublicationType
?:journal
  • Contemporary clinical trials
is ?:pmid of
?:pmid
?:pmid
  • 34166841
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.536
?:rankingScore_hIndex
  • 48
is ?:relation_isRelatedTo_publication of
?:title
  • Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer\'s.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34166841>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34166841>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all